NEWS

Feds Taking “Stock” of Curaleaf

 

U.S.-based medical and cannabis operator, Curaleaf, finds itself in more problems since the Food and Drug Administration (FDA) publicized that the firm was making unsubstantial health claims about its products. While the CuraLeaf did remove all claims after being warned by the federal agency, it has now been accused of violating federal securities law. Simply put, Curaleaf’s health claims is reasoned as a securities violation because the spreading of falsified material is trusted as a scheme to increase the firm’s securities market prices.

RECENTLY FEATURED IN NEWS

News November

Austin L. Ray Black Market Tops Cali Cannabis Sales According to an unofficial audit on illicit and legal operating cannabis stores tin California, there were

Read More »

Good News for CBD Growing

The US Drug Enforcement Administration is “moving forward” and “providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers.”

Read More »